Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950117-12-000249
Filing Date
2012-02-03
Accepted
2012-02-03 14:14:31
Documents
1
Period of Report
2012-02-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 cfp_20421.html 4  
1 FORM 4 cfp_20421.xml 4 3633
  Complete submission text file 0000950117-12-000249.txt   5127
Mailing Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711
Business Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711 302 355-0650
iBio, Inc. (Issuer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711
Business Address
MUSING JULES A. (Reporting) CIK: 0001524216 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35023 | Film No.: 12569206